Breast Cancer Now media statements
We respond to Elle Macpherson sharing her breast cancer diagnosis 7 years ago
Jane Murphy, clinical nurse specialist at Breast Cancer Now, said:
Breast Cancer Now responds to latest vacancy rates among screening mammographers
Responding to the latest vacancy rates among screening mammographers, Rachael Franklin, interim chief executive at Breast Cancer Now, said:
We respond to Royal College of Radiologists' 2023 Clinical Radiology and Oncology Census Reports
Baroness Delyth Morgan, chief executive at Breast Cancer Now, said:
We respond to new data presented at ASCO 2024 congress, which found that women taking Enhertu survived without their breast cancer growing for an average of 13 months
Dr Simon Vincent, director of research, support and influencing at Breast Cancer Now, said:
We respond to research that has shown breast cancer rates increasing amongst younger people
Dr Simon Vincent, director of research, support and influencing at Breast Cancer Now, said:
We respond to research about a new blood test that predicts recurrence of breast cancer
Dr Simon Vincent, director of research, support and influencing at Breast Cancer Now, said:
We respond to NICE recommendation of tumour profiling tests to guide adjuvant chemotherapy decisions for certain patients
Baroness Delyth Morgan, chief executive at Breast Cancer Now, said:
Breast Cancer Now responds to study highlighting increased risk of second cancers among breast cancer survivors
Dr Simon Vincent, director of research, support and influencing at Breast Cancer Now, said:
Breast Cancer Now responds to new evidence that ‘exhausted’ immune cells in healthy women could be target for breast cancer prevention
Dr Simon Vincent, director of research, support and influencing at Breast Cancer Now, said:
Breast Cancer Now responds to new research into how breast cancer cells become dormant and evade treatment
Dr Simon Vincent, director of research, support and influencing at Breast Cancer Now, said: